The results revealed that GK expression was notably upregulated in several cancers, including breast cancer, esophageal squamous cell carcinoma (ESCA), and gastric cancer, while it was significantly downregulated in others, such as colon cancer, lung squamous cell carcinoma, and thyroid carcinoma (Supplementary Fig. 1A). Here, GK is linked to squamous cell lung carcinoma.